WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

Search

Hims & Hers Health Inc

Ouvert

SecteurConsommation de base

27.66 -1.04

Résumé

Variation du prix de l'action

24h

Actuel

Min

27.01

Max

28.73

Chiffres clés

By Trading Economics

Revenu

-50M

26M

Ventes

80M

481M

P/E

Moyenne du Secteur

48.755

40.769

BPA

0.227

Marge bénéficiaire

5.409

Employés

1,637

EBITDA

-8.2M

19M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+71.36% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-5.2B

6B

Ouverture précédente

28.7

Clôture précédente

27.66

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Hims & Hers Health Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 avr. 2025, 22:38 UTC

Actions en Tendance

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

1 avr. 2025, 23:15 UTC

Principaux Mouvements du Marché

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 févr. 2025, 15:33 UTC

Principaux Mouvements du Marché

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

18 nov. 2024, 19:07 UTC

Principaux Mouvements du Marché

Hims & Hers Stock Climbs After Former Regulator Autor Joins Board

14 oct. 2024, 15:02 UTC

Principaux Mouvements du Marché

Hims & Hers Health Shares Jump After FDA Set to Reconsider Limits on Knockoff Weight-Loss Drugs

3 oct. 2024, 11:28 UTC

Principaux Mouvements du Marché

Hims & Hers Health Shares Fall After FDA Removes Eli Lilly Obesity Drugs From Shortage List

2 avr. 2025, 16:53 UTC

Actualités

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mars 2025, 15:54 UTC

Actualités

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 févr. 2025, 23:20 UTC

Résultats

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

10 févr. 2025, 12:00 UTC

Actualités

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business -- Heard on the Street -- WSJ

19 déc. 2024, 17:16 UTC

Actualités

FDA Says Shortage of Eli Lilly's Zepbound is Over, But Gives Compounders a Grace Period -- Barrons.com

19 déc. 2024, 15:14 UTC

Actualités

Eli Lilly's Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

19 déc. 2024, 15:02 UTC

Actualités

The Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

16 déc. 2024, 13:47 UTC

Actualités

The Weight-Loss Drug Market Is Heading for a Reckoning This Week -- Barrons.com

16 déc. 2024, 07:00 UTC

Actualités

The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect. -- Barrons.com

3 oct. 2024, 14:45 UTC

Actualités

Eli Lilly's Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 13:12 UTC

Actualités

Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 11:45 UTC

Actualités

Update: Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 10:14 UTC

Actualités

Update: Eli Lilly's Weight-Loss Drugs No Longer In Shortage. It's Bad News for These Stocks. -- Barrons.com

2 août 2024, 17:52 UTC

Acquisitions, Fusions, Rachats

Hims & Hers Plan to Sell Knockoff Weight Loss Drug Looking Shaky -- Barrons.com

26 juin 2024, 11:00 UTC

Actualités
Acquisitions, Fusions, Rachats

The War Over Cheaper Ozempic Won't End Well for Some Investors -- Heard on the Street -- WSJ

24 mai 2024, 20:37 UTC

Résultats

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week -- WSJ

Comparaison

Variation de prix

Hims & Hers Health Inc prévision

Objectif de Prix

By TipRanks

71.36% hausse

Prévisions sur 12 Mois

Moyen 45.77 USD  71.36%

Haut 85 USD

Bas 22 USD

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

13 ratings

5

Achat

6

Maintien

2

Vente

Score Technique

By Trading Central

27.2 / 29Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.